PRINCETON, N.J., Dec. 16, 2024 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback